- Home
- PBYI vs BRT Comparison
PBYI vs BRT Comparison
Compare PBYI & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | BRT |
|---|---|---|
| Founded | 2010 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 285.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | BRT |
|---|---|---|
| Price | $5.96 | $14.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 372.8K | 62.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 6.92% |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $211,995,000.00 | $98,001,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | $8.01 | ★ N/A |
| Revenue Growth | N/A | ★ 1.30 |
| 52 Week Low | $2.58 | $14.00 |
| 52 Week High | $6.12 | $19.01 |
Technical Indicators
Market Signals| Indicator | PBYI | BRT |
|---|---|---|
| Relative Strength Index (RSI) | 66.14 | 44.45 |
| Support Level | $5.51 | $14.18 |
| Resistance Level | $5.73 | $15.33 |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 95.76 | 24.33 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.